CurveBeam AI (ASX:CVB) Net Margin % : -414.45% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CurveBeam AI's Net Income for the six months ended in Dec. 2023 was A$-14.17 Mil. CurveBeam AI's Revenue for the six months ended in Dec. 2023 was A$3.42 Mil. Therefore, CurveBeam AI's net margin for the quarter that ended in Dec. 2023 was -414.45%.

The historical rank and industry rank for CurveBeam AI's Net Margin % or its related term are showing as below:

ASX:CVB' s Net Margin % Range Over the Past 10 Years
Min: -635.97 Med: -129.66 Max: -93.73
Current: -414.45

ASX:CVB's Net Margin % is ranked worse than
87.44% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -1.675 vs ASX:CVB: -414.45

CurveBeam AI Net Margin % Historical Data

The historical data trend for CurveBeam AI's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Net Margin % Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Net Margin %

-93.73

-129.66

-635.97

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Net Margin %	-	-133.87	-126.35	-	-414.45

Competitive Comparison of CurveBeam AI's Net Margin %

For the Medical Devices subindustry, CurveBeam AI's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CurveBeam AI's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Net Margin % distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's Net Margin % falls into.

CurveBeam AI Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CurveBeam AI's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-51.227	/	8.055
	=	-635.97 %

CurveBeam AI's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-14.166	/	3.418
	=	-414.45 %

CurveBeam AI (ASX:CVB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

CurveBeam AI Net Margin % Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines